Cargando…
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways
AIM: Diabetic nephropathy (DN) is the primary cause of end-stage renal disease worldwide. Although etiology for DN is complex and still needs to be fully understood, lipid metabolism disorder is found to play a role in it. Previously, we found Yishen Huashi (YSHS) granule could inhibit diabetic dama...
Autores principales: | Zhao, Tingting, Xiang, Qian, Lie, Beifeng, Chen, Deqi, Li, Minyi, Zhang, Xi, Yang, Junzheng, He, Bao, Zhang, Wei, Dong, Ruixue, Liu, Yadi, Gu, Junling, Zhu, Quan, Yao, Yijing, Duan, Tingting, Li, Zhenghai, Xu, Youhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018483/ https://www.ncbi.nlm.nih.gov/pubmed/36938470 http://dx.doi.org/10.1016/j.heliyon.2023.e14171 |
Ejemplares similares
-
Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
por: Zhao, Tingting, et al.
Publicado: (2022) -
Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy
por: Zhang, Panke, et al.
Publicado: (2022) -
Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022) -
Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance
por: Jia, Jia, et al.
Publicado: (2020) -
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
por: Zhang, Ziyuan, et al.
Publicado: (2022)